Status and phase
Conditions
Treatments
About
This is a randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of 611 when used in combination with topical corticosteroid (TCS) treatment compared with placebo in combination with TCS treatment for moderate-to-severe atopic dermatitis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
400 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Qinghong Zhou
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal